Core Insights - Mobile-health Network Solutions (MNDR) has been awarded the 2025 Brands For Good Distinction Award in the category of Technology For Good, recognizing its contributions to social and environmental challenges [1][2] - The award ceremony took place on July 23, 2025, in Singapore, celebrating 41 companies from 80 nominations, highlighting the significance of technology in addressing societal issues [2][3] - MNDR's co-CEO, Dr. Siaw Tung Yeng, emphasized the company's commitment to improving healthcare accessibility through AI technology, which has been integrated into three innovative products in 2025 [4][7] Product Innovations - The first product, AI Agent, launched in January 2025, aims to reduce administrative burdens on healthcare providers and enhance workflow efficiency [4] - The second product, AI Notes, introduced in March 2025, automates the documentation process by capturing doctor-patient conversations and generating structured clinical notes in real-time [5] - The third product, AI Checker, deployed earlier this month, provides immediate feedback on the quality of doctors' consultations by evaluating notes against the QNOTE framework, a recognized medical standard [6] Company Overview - Mobile-health Network Solutions is a leading AI-powered digital health platform based in Singapore, with operations across Southeast Asia and plans for expansion into the US [9] - The company's mission is to make healthcare accessible, intelligent, and human through technology, providing telemedicine and AI-driven health tools [10]

Core Insights - Mobile-health Network Solutions (MNDR) launched an at-the-market (ATM) equity offering to raise up to $300 million to accelerate the growth of its AI-powered digital health platform [1][3] - The company aims to use the proceeds to develop large language models for diagnostics, expand AI-driven teleconsultation services in Asia, and build a pharmacy delivery infrastructure [3][4] Financial Performance - MNDR reported revenue of $4.3 million for the six-month period ended December 31, 2024, down from $6.6 million in the same period a year earlier [4][5] - The decline in revenue was attributed to the closure of a clinic in Singapore, which reduced telemedicine service usage, although sales of medicine and medical devices increased [5] Strategic Initiatives - In the first half of 2025, MNDR secured $10 million in funding for its AI Agent, launched AI Notes for transcribing doctor-patient conversations, acquired Indonesian pharmacy and telehealth platform Lifepack, and announced plans for a tele-dentistry service [6] - The company is optimistic about recovering and surpassing previous revenue levels, aiming for breakeven by the second half of FY2025 and profitability before the first half of FY2027 [7] Market Trends - Telehealth has become a standard delivery channel in the U.S., particularly among younger generations, with nearly 30% of Generation Z and millennials using telehealth for their most recent healthcare encounter [8]

Mobile-health Network Solutions Launches $300 Million At-the-Market Offering to Drive AI-Powered Healthcare and Pharmacy Delivery ExpansionJuly 17, 2025 8:00 AM EDT | Source: Mobile-health Network SolutionsSingapore, Singapore--(Newsfile Corp. - July 17, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading AI-powered digital health platform, today announced the launch of an At-the-Market (ATM) equity offering to raise up to US$300 million. This strategic ...

Core Viewpoint - Mobile-health Network Solutions (MNDR) is transitioning to a leaner, asset-light model focused on AI-driven virtual care, aiming for scalability and profitability despite short-term revenue declines due to the closure of its CityGate clinic in Singapore [2][3]. Financial Performance - For H1 FY2025, MNDR reported revenue of US$4.3 million, down from US$6.6 million in H1 FY2024, and a net loss of US$(1.7 million) compared to US$(1.5 million) in the same period last year [7]. - Cash and cash equivalents decreased to US$2.6 million from US$6.7 million in H1 FY2024 [7]. Strategic Initiatives - The closure of the CityGate clinic is seen as a pivotal moment in the company's transformation towards a globally scalable, AI-focused platform [3]. - In April 2025, MNDR acquired Lifepack, enhancing its telehealth and pharmacy services for Indonesia's 280 million people, many of whom are underserved [4]. - The company secured US$10 million in funding in January 2025 to advance its AI-driven healthcare solutions, including the AI Agent platform [5]. Operational Developments - MNDR has integrated AI agents into its MaNaDr app to reduce operational costs while improving care and service delivery [8]. - The launch of AI Notes in March 2025 automates clinical note-taking for doctors, enhancing efficiency [11]. - A tele-dentistry service was announced in May 2025, allowing patients to perform AI-enhanced dental scans at home [11]. Future Outlook - The company anticipates that recent initiatives will lead to higher revenue and aims to achieve breakeven by H2 FY2025 and profitability before H1 FY2027 [9].

Company Overview - Mobile-health Network Solutions is a leading MedTech innovator ranked 41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies [4] - The company is the first telehealth provider from the Asia-Pacific region to be listed in the US, offering personalized and reliable medical attention globally [4] - Its platform enables healthcare providers to reach users through virtual clinics without start-up costs, connecting them to a global network of peer-to-peer support groups and partners [4] Share Repurchase Program - The Board of Directors has approved a share repurchase program to buy back up to 214,000 Class A Ordinary Shares, effective immediately for one year [1] - The program reflects the Board's confidence in the company's long-term growth prospects and is seen as a compelling use of capital at current share prices [2] - Repurchases may occur through various means, including open market transactions and privately negotiated transactions, depending on market conditions and regulatory requirements [2][3] Market Position and Strategy - The company believes its current share price does not reflect its intrinsic value or the strength of its fundamentals [2] - The share repurchase program does not obligate the company to repurchase a specific number of shares and can be modified or terminated at the company's discretion [3]

Core Insights - Mobile-health Network Solutions (MNDR) has launched a new tele-dentistry service that allows patients to perform AI-enhanced dental scans at home using the MNDR telemedicine app, with expert-reviewed reports delivered within 24 hours [2][3][4] - The service aims to encourage Southeast Asian patients, who often do not visit dentists regularly, to seek dental care more frequently [3][7] - The tele-dentistry package includes guided steps for capturing intraoral images and receiving AI-generated reports, which will highlight potential dental issues [4][5] Company Developments - MNDR has signed a Memorandum of Understanding (MOU) with Oral Link Pte Ltd and Elite Dental Group Singapore Pte Ltd to facilitate the tele-dentistry service [4][6] - The service is set to launch in Singapore in the summer of 2025, with plans for expansion into Malaysia, Indonesia, and the Philippines by mid-2026 [6] - MNDR will earn an appointment booking fee and platform usage fee for each tele-dentistry session [6] Industry Context - According to the World Health Organization, oral diseases affect nearly 3.7 billion people globally, with untreated dental caries being the most common health condition [9] - The introduction of AI-enabled dental scans is expected to improve early detection of dental issues, potentially increasing patient engagement in dental care [7][9]

Summary of the Conference Call for Mobile Health Network Solution (MNDR) Company Overview - **Company Name**: Mobile Health Network Solution - **Ticker**: MNDR - **Market**: Primarily focused on the APAC region, particularly Singapore, with plans for expansion into Indonesia, Malaysia, and Vietnam [1][26][57] Core Industry Insights - **Telehealth Market**: The company is a leading provider of teleconsultation services in Southeast Asia, with a significant volume of consultations conducted over the past seven years [5][33] - **AI Integration**: The company is leveraging AI technology to enhance healthcare delivery, including the development of an AI companion for patients and an AI adviser for doctors [28][31] Key Points and Arguments - **Market Position**: Ranked as one of the fastest-growing healthcare and life science companies in Singapore and the APAC region, with a Financial Times ranking of 41 in 2024 [5][26] - **User Base**: Over 2 million users in Singapore, with a high user retention rate of nearly 99% [42][56] - **Affordability**: Offers teleconsultation services at a cost of less than $6 to $7, making healthcare accessible and affordable [40] - **Growth Potential**: Less than 20% of care in Singapore is currently virtual, indicating significant growth potential as the company aims to scale virtual care [48][49] Future Plans and Strategies - **Expansion**: Plans to expand operations into Indonesia, Malaysia, and Vietnam, targeting a combined population of nearly 500 million [57][58] - **AI Development**: Focus on developing AI capabilities to automate clinical documentation and enhance patient-doctor interactions [31][54] - **Global Reach**: The platform is designed for global scalability, allowing users worldwide to access services through a mobile app [58] Financial Insights - **Liquidity**: The company has a standby line of $10 million and aims for operational profitability within one to two years [53][54] - **Marketing Strategy**: Minimal marketing expenditure (less than $100,000) with growth driven primarily by word-of-mouth [55] Additional Noteworthy Information - **Healthcare Transformation**: The company is positioned to redefine healthcare delivery through AI, aiming for a seamless interaction between patients and healthcare providers [44][60] - **Unique Value Proposition**: The combination of high consultation volume, healthcare-focused data accumulation, and AI-driven solutions sets the company apart from generalist AI solutions [63][64] Conclusion - The company is at the forefront of a transformative period in healthcare, leveraging AI to enhance accessibility and efficiency in telehealth services, with ambitious plans for growth and expansion in the coming years [41][62]

Core Viewpoint - Mobile-health Network Solutions (MNDR) has announced a new tele-dentistry service that utilizes AI-enabled dental scans, aimed at improving dental care accessibility in Southeast Asia, particularly for patients who do not regularly visit dentists [1][2][6]. Company Overview - MNDR is a leading MedTech innovator ranked 41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies and is the first telehealth provider from the Asia-Pacific region to be listed in the US [9]. Service Details - The new tele-dentistry service will allow patients to perform AI-enhanced dental scans at home using the MaNaDr telemedicine app, with expert-reviewed reports delivered within 24 hours [1][3]. - Patients can purchase a tele-dentistry package through the app, capture intraoral images with their smartphones, and receive detailed AI-generated reports highlighting potential dental issues [3][4]. - The service will launch in Singapore in summer 2025, with plans for expansion to Malaysia, Indonesia, and the Philippines by mid-2026 [5]. Market Need - The service targets the significant population in Southeast Asia that does not visit a dentist at least once a year, potentially at higher risk for dental conditions [6][7]. - According to the World Health Organization, oral diseases affect nearly 3.7 billion people globally, with untreated dental caries being the most common health condition [7]. Revenue Model - MNDR will earn an appointment booking fee and platform usage fee for each tele-dentistry session conducted through the MaNaDr app [5].

Company Overview - Mobile-health Network Solutions (NASDAQ: MNDR) is a leading MedTech innovator recognized among Asia-Pacific's high-growth companies, ranked 41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies [10] - The company is the first telehealth provider from the Asia-Pacific region to be listed in the US, offering personalized and reliable medical attention globally through its platform [10] Upcoming Conferences - The company will present at the Sidoti May Virtual Investor Conference on May 21-22, 2025, with presentations by co-CEOs Dr. Tung Yeng Siaw and Dr. Rachel Teoh starting at 8:30 AM ET on May 21 [2][3] - Additionally, the company will participate in the "2025 Virtual Tech Conference" hosted by Maxim Group LLC from June 3-5, 2025, with their presentation scheduled for June 4 at 8:30 AM ET [3] Conference Themes - The conferences will explore the rapid evolution of technology and its impact on various sectors, including healthcare, and how emerging growth companies are leveraging quantum computing and AI for future positioning [4]

Core Viewpoint - Mobile-health Network Solutions (MNDR) intends to acquire Lifepack, a leading pharmacy and telehealth platform in Indonesia, to expand its presence in the high-growth Indonesian healthcare market [1][2][5]. Group 1: Acquisition Details - The acquisition of Lifepack is valued at up to US$7.2 million, contingent upon Lifepack achieving its revenue target for 2025 [5]. - The consideration will be satisfied through the issuance of up to 875,000 new MNDR Class A Ordinary Shares at an issue price of US$8 per share, along with a non-refundable cash payment of US$0.2 million [5][7]. - The US$8 per share issue price represents a substantial premium to MNDR's current share price of approximately US$1.42 as of April 29, 2025, indicating the perceived value of the acquisition [5]. Group 2: Strategic Importance - The acquisition aligns with Indonesia's primary care needs and complements MNDR's telehealth expertise, aiming to serve 280 million people across 17,000 islands [2][3]. - Lifepack's platform is compliant with BPOM regulations and is positioned to lead the Indonesian digital pharmacy market, enhancing healthcare access, especially in remote areas [4][3]. - The partnership aims to create a transformative online-to-offline (O2O) healthcare platform that addresses the unique needs of Indonesia's diverse population [3][4]. Group 3: Lifepack's Operations - Lifepack operates a hybrid model delivering BPOM-licensed prescription drugs, over-the-counter medications, supplements, and medical equipment through both online and offline channels [3][9]. - The platform offers consultations with healthcare professionals via its mobile app, website, and social media, supported by an expanding warehouse network [3][9]. - Lifepack focuses on chronic disease management and preventive care, addressing the growing demand for affordable medical services in Indonesia [3][4].